- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03863717
Investigation of the Effectiveness of Upper Limb Exercise in COPD Patients
The aim of the study is to investigate the efficacy of upper limb exercise training in Chronic Obstructive Pulmonary Disease (COPD) patients. For the purpose of the study, a controlled trial will be conducted within Respiratory Clinic of Nicosia General Hospital. The sample will be divided in two groups. The intervention group will participate in a pulmonary rehabilitation program which includes upper and lower extremities exercises, with addition of arm ergometer. The second group (control group) will participate in the same program but without arm ergometer training.
The study's hypothesis is that the intervention group will improve the outcome measures significantly better than the control group.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Christos Karagiannis
- Phone Number: 0035799912547
- Email: c.karayiannis@euc.ac.cy
Study Locations
-
-
-
Nicosia, Cyprus
- Recruiting
- Respiratory Clinic, Nicosia General Hospital
-
Contact:
- Andreas Georgiou
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of COPD confirmed by clinical examination and a pulmonary function test
- Stable clinical condition (without recent respiratory system infections or any exacerbation of the disease)
- Patients must be willing to re evaluate at the end of the study
- Patients must be willing to give written consent for their participation in the study
Exclusion Criteria:
- Age < 18 years old
- Unstable cardiac disease
- Musculoskeletal and neurological diseases that could affect exercise performance or preclude exercise
- Patients of COPD final stage or other serious disease final stage
- Significant cognitive or psychiatric impairment that would lead to an inability to follow simple commands in a group setting
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arm Endurance Exercise Training Group
Pulmonary Rehabilitation Program including Upper Limb Endurance Exercise Training with arm cycle ergometer
|
Pulmonary Rehabilitation Program including Upper Limb Endurance Exercise Training with arm cycle ergometer
Other Names:
|
Active Comparator: Control Group
Pulmonary Rehabilitation Program without Upper Limb Endurance Exercise Training
|
Pulmonary Rehabilitation Program without Upper Limb Endurance Exercise Training
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Upper Limb Muscle Strength, biceps brachii
Time Frame: Before Intervention
|
Assess biceps brachii via hand-held dynamometer Micro FET2
|
Before Intervention
|
Upper Limb Muscle Strength, biceps brachii
Time Frame: At 3 months (at the end of intervention)
|
Assess biceps brachii via hand-held dynamometer Micro FET2
|
At 3 months (at the end of intervention)
|
Upper Limb Muscle Strength, biceps brachii
Time Frame: Change from Baseline Biceps Brachii Muscle Strength at 3 months
|
Assess biceps brachii via hand-held dynamometer Micro FET2
|
Change from Baseline Biceps Brachii Muscle Strength at 3 months
|
Upper Limb Muscle Strength, triceps
Time Frame: Before Intervention
|
Assess triceps via hand-held dynamometer Micro FET2
|
Before Intervention
|
Upper Limb Muscle Strength, triceps
Time Frame: At 3 months (at the end of intervention)
|
Assess triceps via hand-held dynamometer Micro FET2
|
At 3 months (at the end of intervention)
|
Upper Limb Muscle Strength, triceps
Time Frame: Change from Baseline Triceps Muscle Strength at 3 months
|
Assess triceps via hand-held dynamometer Micro FET2
|
Change from Baseline Triceps Muscle Strength at 3 months
|
Upper Limb Muscle Strength, hand-grip
Time Frame: Before Intervention
|
Assess via jamar hand dynamometer
|
Before Intervention
|
Upper Limb Muscle Strength, hand-grip
Time Frame: At 3 months (at the end of intervention)
|
Assess via jamar hand dynamometer
|
At 3 months (at the end of intervention)
|
Upper Limb Muscle Strength, hand-grip
Time Frame: Change from Baseline Handgrip Muscle Strength at 3 months
|
Assess via jamar hand dynamometer
|
Change from Baseline Handgrip Muscle Strength at 3 months
|
Dyspnea, modified Borg Scale
Time Frame: Before Intervention
|
Assess via modified Borg Scale 0 - 10, 0 = no dyspnea, 10 = maximal dyspnea
|
Before Intervention
|
Dyspnea, modified Borg Scale
Time Frame: At 3 months (at the end of intervention)
|
Assess via modified Borg Scale 0 - 10, 0 = no dyspnea, 10 = maximal dyspnea
|
At 3 months (at the end of intervention)
|
Dyspnea, modified Borg Scale
Time Frame: Change from Baseline Dyspnea at 3 months
|
Assess via modified Borg Scale 0 - 10, 0 = no dyspnea, 10 = maximal dyspnea
|
Change from Baseline Dyspnea at 3 months
|
Dyspnea, mMRC Scale
Time Frame: Before Intervention
|
Assess via modified Medical Research Council Dyspnea Scale 0 - 4, 0 = breathless only with strenuous exercise, 4 = too breathless to leave the house or breathless when dressing
|
Before Intervention
|
Dyspnea, mMRC Scale
Time Frame: At 3 months (at the end of intervention)
|
Assess via modified Medical Research Council Dyspnea Scale 0 - 4, 0 = breathless only with strenuous exercise, 4 = too breathless to leave the house or breathless when dressing
|
At 3 months (at the end of intervention)
|
Dyspnea, mMRC Scale
Time Frame: Change from Baseline Dyspnea at 3 months
|
Assess via modified Medical Research Council Dyspnea Scale 0 - 4, 0 = breathless only with strenuous exercise, 4 = too breathless to leave the house or breathless when dressing
|
Change from Baseline Dyspnea at 3 months
|
Fatigue
Time Frame: Before Intervention
|
Assess via modified Borg Scale (0 - 10), 0 = no fatigue, 10 = maximal fatigue
|
Before Intervention
|
Fatigue
Time Frame: At 3 months (at the end of intervention)
|
Assess via modified Borg Scale (0 - 10), 0 = no fatigue, 10 = maximal fatigue
|
At 3 months (at the end of intervention)
|
Fatigue
Time Frame: Change from Baseline Fatigue at 3 months
|
Assess via modified Borg Scale (0 - 10), 0 = no fatigue, 10 = maximal fatigue
|
Change from Baseline Fatigue at 3 months
|
Health-related Quality of Life, SGRQ
Time Frame: Before Intervention
|
Assess via Saint George Respiratory Questionnaire, A total score incorporates scores from each component of the SGRQ which ranges from 1 to 100, where 0 indicates best health and 100 indicates worst health
|
Before Intervention
|
Health-related Quality of Life, SGRQ
Time Frame: At 3 months (at the end of intervention)
|
Assess via Saint George Respiratory Questionnaire, A total score incorporates scores from each component of the SGRQ which ranges from 1 to 100, where 0 indicates best health and 100 indicates worst health
|
At 3 months (at the end of intervention)
|
Health-related Quality of Life, SGRQ
Time Frame: Change from Baseline at 3 months
|
Assess via Saint George Respiratory Questionnaire, A total score incorporates scores from each component of the SGRQ which ranges from 1 to 100, where 0 indicates best health and 100 indicates worst health
|
Change from Baseline at 3 months
|
Health-related Quality of Life, CAT
Time Frame: Before Intervention
|
Assess via COPD Assessment Test (CAT), Range of CAT scores from 0-40.
Higher scores denote a more severe impact of COPD on a patient's life.
|
Before Intervention
|
Health-related Quality of Life, CAT
Time Frame: At 3 months (at the end of intervention)
|
Assess via COPD Assessment Test (CAT), Range of CAT scores from 0-40.
Higher scores denote a more severe impact of COPD on a patient's life.
|
At 3 months (at the end of intervention)
|
Health-related Quality of Life, CAT
Time Frame: Change from Baseline at 3 months
|
Assess via COPD Assessment Test (CAT), Range of CAT scores from 0-40.
Higher scores denote a more severe impact of COPD on a patient's life.
|
Change from Baseline at 3 months
|
Activities of Daily Living with Upper Limbs
Time Frame: Before Intervention
|
Assess via total time need to perform 3 daily activities: (i) simulating of window cleaning, (ii) dry 10 dishes and putting them on a shelf above shoulder level and (iii) putting three packages, each weighing 1000 g, on a shelf above shoulder level
|
Before Intervention
|
Activities of Daily Living with Upper Limbs
Time Frame: At 3 months (at the end of intervention)
|
Assess via total time need to perform 3 daily activities: (i) simulating of window cleaning, (ii) dry 10 dishes and putting them on a shelf above shoulder level and (iii) putting three packages, each weighing 1000 g, on a shelf above shoulder level
|
At 3 months (at the end of intervention)
|
Activities of Daily Living with Upper Limbs
Time Frame: Change from Baseline time at 3 months
|
Assess via total time need to perform 3 daily activities: (i) simulating of window cleaning, (ii) dry 10 dishes and putting them on a shelf above shoulder level and (iii) putting three packages, each weighing 1000 g, on a shelf above shoulder level
|
Change from Baseline time at 3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ΕΕΒΚ/ΕΠ/2017/18
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on Arm Endurance Exercise Training
-
Landsteiner InstitutLund University; Medical University of Vienna; Mein Hanusch-Krankenhaus; Fondazione... and other collaboratorsCompletedType 2 Diabetes Mellitus | Insulin ResistanceAustria
-
Rigshospitalet, DenmarkCompleted
-
Charite University, Berlin, GermanyUnknownHeart Failure | Sudden Cardiac Death | Cardiac Resynchronisation TherapyGermany
-
University of GuelphCompletedOverweight or ObesityCanada
-
LHL HelseUniversity of Oslo; Hasselt UniversityCompleted
-
Rigshospitalet, DenmarkCompleted
-
UNC Lineberger Comprehensive Cancer CenterCompletedStem Cell Transplantation, HematopoieticUnited States
-
Cliniques universitaires Saint-Luc- Université...CompletedHuman Immunodeficiency Virus
-
University of LeipzigGerman Research FoundationCompletedHeart Failure | AgeingGermany
-
Mayo ClinicCompleted